Login
Home
Charts
Search
Watchlist
Products

Sunrest Lifescience Ltd

SUNREST·NSE
₹38.45+4.63%Tue, 22 Sept '26
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Sunrest Lifescience Ltd

SUNREST
NSE
₹38.45
+4.63%
|Tue, 22 Sept '26
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹17Cr
Close
Close Price
₹38.45
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
17.48
PS
Price To Sales
0.23
Revenue
Revenue
₹71Cr
Rev Gr TTM
Revenue Growth TTM
112.00%
PAT Gr TTM
PAT Growth TTM
297.51%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
15183437
Growth YoY
Revenue Growth YoY%
121.0104.3
Expenses
ExpensesCr
14163230
Operating Profit
Operating ProfitCr
1227
OPM
OPM%
5.811.77.218.4
Other Income
Other IncomeCr
0003
Interest Expense
Interest ExpenseCr
0011
Depreciation
DepreciationCr
0011
PBT
PBTCr
1229
Tax
TaxCr
0002
PAT
PATCr
1117
Growth YoY
PAT Growth YoY%
12.1359.4
NPM
NPM%
3.87.91.917.8
EPS
EPS₹
2.53.01.50.7
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
15183437
Growth YoY
Revenue Growth YoY%
121.0104.3
Expenses
ExpensesCr
14163230
Operating Profit
Operating ProfitCr
1227
OPM
OPM%
5.811.77.218.4
Other Income
Other IncomeCr
0003
Interest Expense
Interest ExpenseCr
0011
Depreciation
DepreciationCr
0011
PBT
PBTCr
1229
Tax
TaxCr
0002
PAT
PATCr
1117
Growth YoY
PAT Growth YoY%
12.1359.4
NPM
NPM%
3.87.91.917.8
EPS
EPS₹
2.53.01.50.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026
Revenue
RevenueCr
3371
Growth
Revenue Growth%
112.0
Expenses
ExpensesCr
3061
Operating Profit
Operating ProfitCr
310
OPM
OPM%
9.014.4
Other Income
Other IncomeCr
03
Interest Expense
Interest ExpenseCr
01
Depreciation
DepreciationCr
01
PBT
PBTCr
310
Tax
TaxCr
12
PAT
PATCr
28
Growth
PAT Growth%
297.5
NPM
NPM%
6.011.3
EPS
EPS₹
4.28.9
Financial YearMar 2025Mar 2026
Revenue
RevenueCr
3371
Growth
Revenue Growth%
112.0
Expenses
ExpensesCr
3061
Operating Profit
Operating ProfitCr
310
OPM
OPM%
9.014.4
Other Income
Other IncomeCr
03
Interest Expense
Interest ExpenseCr
01
Depreciation
DepreciationCr
01
PBT
PBTCr
310
Tax
TaxCr
12
PAT
PATCr
28
Growth
PAT Growth%
297.5
NPM
NPM%
6.011.3
EPS
EPS₹
4.28.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial Year
Equity Capital
Equity CapitalCr
Reserves
ReservesCr
Current Liabilities
Current LiabilitiesCr
Non Current Liabilities
Non Current LiabilitiesCr
Total Liabilities
Total LiabilitiesCr
Current Assets
Current AssetsCr
Non Current Assets
Non Current AssetsCr
Total Assets
Total AssetsCr
Financial Year
Equity Capital
Equity CapitalCr
Reserves
ReservesCr
Current Liabilities
Current LiabilitiesCr
Non Current Liabilities
Non Current LiabilitiesCr
Total Liabilities
Total LiabilitiesCr
Current Assets
Current AssetsCr
Non Current Assets
Non Current AssetsCr
Total Assets
Total AssetsCr

Cash Flow

Consolidated
Standalone
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
30
Investing Cash Flow
Investing Cash FlowCr
-1-3
Financing Cash Flow
Financing Cash FlowCr
04
Net Cash Flow
Net Cash FlowCr
11
Free Cash Flow
Free Cash FlowCr
CFO To PAT
CFO To PAT%
145.3-0.6
CFO To EBITDA
CFO To EBITDA%
96.7-0.5
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
30
Investing Cash Flow
Investing Cash FlowCr
-1-3
Financing Cash Flow
Financing Cash FlowCr
04
Net Cash Flow
Net Cash FlowCr
11
Free Cash Flow
Free Cash FlowCr
CFO To PAT
CFO To PAT%
145.3-0.6
CFO To EBITDA
CFO To EBITDA%
96.7-0.5

Ratios

Consolidated
Standalone
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
231617
Price To Earnings
Price To Earnings
11.53.917.5
Price To Sales
Price To Sales
0.70.20.2
Price To Book
Price To Book
1.40.80.8
EV To EBITDA
EV To EBITDA
3.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
9.014.414.4
NPM
NPM%
6.011.311.3
ROCE
ROCE%
ROE
ROE%
ROA
ROA%
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
231617
Price To Earnings
Price To Earnings
11.53.917.5
Price To Sales
Price To Sales
0.70.20.2
Price To Book
Price To Book
1.40.80.8
EV To EBITDA
EV To EBITDA
3.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
9.014.414.4
NPM
NPM%
6.011.311.3
ROCE
ROCE%
ROE
ROE%
ROA
ROA%
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Sunrest Lifescience Ltd

  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/ulr0w89e94bazrjxhovvicwy.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/rungygz8gq9x86xioucc8tsl.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/h0iyu2zwjm9d8geqryimxo5a.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/9kbjcqsw4cw5uqkkqdo7f62c.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/o0tarw5wc84tlol034yjecge.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/aogby1gz0vqkb8p2rkg8o8i4.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/5qlfj438rsyekmuku6vt4sla.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/5ev7fsi3q3u35os1drsrlxjm.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies